| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Common Stock | Options Exercise | $2,610 | +100 | +0.01% | $26.10 | 668,045 | 07 Feb 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | $13,729 | -100 | -0.01% | $137.29 | 667,945 | 07 Feb 2022 | Direct | F1, F2 |
| transaction | SGEN | Common Stock | Options Exercise | $93,281 | +3,574 | +0.54% | $26.10 | 671,519 | 07 Feb 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | $496,679 | -3,574 | -0.53% | $138.97 | 667,945 | 07 Feb 2022 | Direct | F1, F2, F3 |
| transaction | SGEN | Common Stock | Options Exercise | $234,508 | +8,985 | +1.3% | $26.10 | 676,930 | 07 Feb 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | $1,257,541 | -8,985 | -1.3% | $139.96 | 667,945 | 07 Feb 2022 | Direct | F1, F2, F4 |
| transaction | SGEN | Common Stock | Options Exercise | $106,592 | +4,084 | +0.61% | $26.10 | 672,029 | 07 Feb 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | $575,150 | -4,084 | -0.61% | $140.83 | 667,945 | 07 Feb 2022 | Direct | F1, F2, F5 |
| transaction | SGEN | Common Stock | Options Exercise | $7,830 | +300 | +0.04% | $26.10 | 668,245 | 07 Feb 2022 | Direct | F1 |
| transaction | SGEN | Common Stock | Sale | $42,468 | -300 | -0.04% | $141.56 | 667,945 | 07 Feb 2022 | Direct | F1, F2, F6 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -100 | -0.08% | $0.000000 | 119,201 | 07 Feb 2022 | Common Stock | 100 | $26.10 | Direct | F7 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -3,574 | -3% | $0.000000 | 115,627 | 07 Feb 2022 | Common Stock | 3,574 | $26.10 | Direct | F7 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -8,985 | -7.8% | $0.000000 | 106,642 | 07 Feb 2022 | Common Stock | 8,985 | $26.10 | Direct | F7 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -4,084 | -3.8% | $0.000000 | 102,558 | 07 Feb 2022 | Common Stock | 4,084 | $26.10 | Direct | F7 |
| transaction | SGEN | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -300 | -0.29% | $0.000000 | 102,258 | 07 Feb 2022 | Common Stock | 300 | $26.10 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. |
| F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
| F3 | Reflects sales of common stock executed in multiple transactions at prices ranging from $138.36 to $139.35. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F4 | Reflects sales of common stock executed in multiple transactions at prices ranging from $139.36 to $140.35. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F5 | Reflects sales of common stock executed in multiple transactions at prices ranging from $140.36 to $141.32. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F6 | Reflects sales of common stock executed in multiple transactions at prices ranging from $141.40 to $141.78. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F7 | Options vested at a rate of 25% on 8/20/13 and monthly thereafter until all the options were fully vested on 8/20/16. |